CHRONIC ORAL TETRAHYDROBIOPTERIN TREATMENT IN PATIENTS WITH CORONARY ARTERY DISEASE ELEVATES TOTAL BIOPTERIN LEVELS BUT DOES NOT IMPROVE BIOPTERIN REDOX STATUS OR VASCULAR FUNCTION: A RANDOMISED PLACEBO-CONTROLLED TRIAL

Documenti analoghi

• Chronic oral tetrahydrobiopterin therapy in coronary artery disease elevates total biopterin levels but does not improve redox status or vascular function: a randomized placebo-controlled trial
  di: Cunnington, C, et al.
  Pubblicazione: (2010)
• Tetrahydrobiopterin, responsive, hyperphenylalaninemia without biopterin defiCIency
  di: Shintaku Haruo, et al.
  Pubblicazione: (2000-08-01)
• Genetic variation in GCH1, encoding GTP-cyclohydrolase 1, regulates biopterin levels and endothelial function in atherosclerosis
  di: Van, A, et al.
  Pubblicazione: (2008)
• A Novel Haplotype on GCH1 Gene, Encoding GTP Cyclohydrolase 1, Regulates Vascular Biopterin Synthesis, eNOS Coupling and Vascular Redox in Human Vessels
  di: Antoniades, C, et al.
  Pubblicazione: (2008)
• Altered plasma versus vascular biopterins in human atherosclerosis reveal relationships between endothelial nitric oxide synthase coupling, endothelial function, and inflammation.
  di: Antoniades, C, et al.
  Pubblicazione: (2007)